• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种制备无细胞百日咳疫苗的新方法,该疫苗由百日咳毒素的无热原类毒素和丝状血凝素组成。

A novel process for preparing an acellular pertussis vaccine composed of non-pyrogenic toxoids of pertussis toxin and filamentous hemagglutinin.

作者信息

Tan L U, Fahim R E, Jackson G, Phillips K, Wah P, Alkema D, Zobrist G, Herbert A, Boux L, Chong P

机构信息

Connaught Laboratories Limited, Willodale, Ontario, Canada.

出版信息

Mol Immunol. 1991 Mar;28(3):251-5. doi: 10.1016/0161-5890(91)90070-z.

DOI:10.1016/0161-5890(91)90070-z
PMID:2017196
Abstract

A novel process for preparing non-pyrogenic toxoids of pertussis toxin (PT) and filamentous hemagglutinin (FHA) is described. The process consists of chromatographies on perlite then on hydroxylapatite. Purification yields for PT and FHA are 62 and 68%, respectively. The purification process takes advantage of the novel use of perlite (a filter aid) for the simultaneous purification of PT and FHA. The hydroxylapatite, in addition to removing the remaining contaminants, also concentrates the antigens. The resulting PT and FHA are approximately 95% pure, and are non-pyrogenic as judged by the rabbit pyrogen test. The purification process is simple, inexpensive, and does not use blood components or toxic substances. The mild conditions in which the PT and FHA are purified ensure the recovery of native protein. The purified PT and FHA are detoxified in the presence of glycerol using glutaraldehyde and formaldehyde, respectively, to produce antigenic components of an acellular pertussis vaccine. The final PT and FHA toxoids are immunogenic in guinea-pigs and have been shown to be protective in the mouse intracerebral challenge test.

摘要

描述了一种制备百日咳毒素(PT)和丝状血凝素(FHA)非热原性类毒素的新方法。该方法包括先在珍珠岩上进行色谱分离,然后在羟基磷灰石上进行色谱分离。PT和FHA的纯化产率分别为62%和68%。该纯化过程利用了珍珠岩(一种助滤剂)的新用途,可同时纯化PT和FHA。羟基磷灰石除了去除残留污染物外,还能浓缩抗原。所得的PT和FHA纯度约为95%,通过兔热原试验判断为非热原性。该纯化过程简单、廉价,且不使用血液成分或有毒物质。纯化PT和FHA的温和条件确保了天然蛋白质的回收。纯化后的PT和FHA分别在甘油存在下使用戊二醛和甲醛进行解毒,以产生无细胞百日咳疫苗的抗原成分。最终的PT和FHA类毒素在豚鼠中具有免疫原性,并已在小鼠脑内攻毒试验中显示出保护作用。

相似文献

1
A novel process for preparing an acellular pertussis vaccine composed of non-pyrogenic toxoids of pertussis toxin and filamentous hemagglutinin.一种制备无细胞百日咳疫苗的新方法,该疫苗由百日咳毒素的无热原类毒素和丝状血凝素组成。
Mol Immunol. 1991 Mar;28(3):251-5. doi: 10.1016/0161-5890(91)90070-z.
2
Simple, efficient purification of filamentous hemagglutinin and pertussis toxin from Bordetella pertussis by hydrophobic and affinity interaction.通过疏水作用和亲和作用从百日咳博德特氏菌中简单、高效地纯化丝状血凝素和百日咳毒素。
J Clin Microbiol. 1990 May;28(5):1062-5. doi: 10.1128/jcm.28.5.1062-1065.1990.
3
Responses to primary and a booster dose of acellular, component, and whole-cell pertussis vaccines initiated at 2 months of age.对2月龄开始接种的无细胞、组分和全细胞百日咳疫苗的初次和加强剂量的反应。
Vaccine. 1996 Jun;14(9):916-22. doi: 10.1016/0264-410x(95)00257-2.
4
The purification and characterization of an acellular pertussis vaccine.一种无细胞百日咳疫苗的纯化与特性分析
J Biol Stand. 1988 Apr;16(2):83-9. doi: 10.1016/0092-1157(88)90035-2.
5
Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.鼻内联合使用重组霍乱毒素B亚单位作为佐剂后,小鼠针对无细胞百日咳疫苗的黏膜和全身抗体反应。
Vaccine. 2003 Mar 7;21(11-12):1165-73. doi: 10.1016/s0264-410x(02)00516-9.
6
Serum antibody response to B. pertussis Tn5 mutants, purified PT and FHA in two different mouse strains and passive protection in the murine intranasal infection model.在两种不同小鼠品系中,针对百日咳杆菌Tn5突变体、纯化的百日咳毒素(PT)和丝状血凝素(FHA)的血清抗体反应以及在小鼠鼻内感染模型中的被动保护作用。
Microb Pathog. 1990 Jan;8(1):37-45. doi: 10.1016/0882-4010(90)90006-c.
7
Preparation of filamentous hemagglutinin from Bordetella pertussis and assay for serum antibodies to filamentous hemagglutinin and pertussis toxin for clinical and public health laboratories.用于临床和公共卫生实验室的百日咳博德特氏菌丝状血凝素的制备以及丝状血凝素和百日咳毒素血清抗体的检测
J Clin Microbiol. 1989 Dec;27(12):2805-10. doi: 10.1128/jcm.27.12.2805-2810.1989.
8
Acellular pertussis vaccine prepared by a simple extraction and toxoiding procedure.
Vaccine. 1987 Sep;5(3):199-207. doi: 10.1016/0264-410x(87)90101-0.
9
Further characterization of Japanese acellular pertussis vaccine prepared in 1988 by 6 Japanese manufacturers.对1988年由6家日本制造商制备的日本无细胞百日咳疫苗的进一步特性分析。
Tokai J Exp Clin Med. 1988;13 Suppl:79-88.
10
Immunogenicity and reactogenicity of the component acellular pertussis vaccine produced by a combination of column purified pertussis toxin and filamentous haemagglutinin.由柱纯化百日咳毒素和丝状血凝素组合生产的组分无细胞百日咳疫苗的免疫原性和反应原性。
Acta Paediatr Jpn. 1995 Oct;37(5):562-74. doi: 10.1111/j.1442-200x.1995.tb03378.x.

引用本文的文献

1
The Immunogenicity of Glutaraldehyde Inactivated PTx Is Determined by the Quantity of Neutralizing Epitopes.戊二醛灭活百日咳毒素的免疫原性由中和表位数量决定。
Vaccines (Basel). 2025 Jul 31;13(8):817. doi: 10.3390/vaccines13080817.
2
Virus-like particles displaying the mature C-terminal domain of filamentous hemagglutinin are immunogenic and protective against respiratory infection in mice.展示丝状血凝素成熟 C 末端结构域的病毒样颗粒具有免疫原性,并能预防小鼠呼吸道感染。
Infect Immun. 2024 Aug 13;92(8):e0027024. doi: 10.1128/iai.00270-24. Epub 2024 Jul 18.
3
Construction of Bordetella pertussis strains that overproduce genetically inactivated pertussis toxin.
过量产生基因失活百日咳毒素的百日咳博德特氏菌菌株的构建。
Appl Environ Microbiol. 1992 Jan;58(1):208-14. doi: 10.1128/aem.58.1.208-214.1992.